Open | - |
Close | - |
Volume / Avg. | 0 / 940.489K |
Day Range | - - - |
52 Wk Range | 1.481 - 5.960 |
Market Cap | $15.433M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immuron (NASDAQ: IMRN) through any online brokerage.
Other companies in Immuron’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN), Evaxion Biotech (NASDAQ:EVAX) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Immuron (NASDAQ: IMRN) was reported by HC Wainwright & Co. on Wednesday, October 18, 2017. The analyst firm set a price target for 15.00 expecting IMRN to rise to within 12 months (a possible 453.51% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Immuron (NASDAQ: IMRN) is $2.71 last updated March 18, 2024 at 7:08 PM EDT.
There are no upcoming dividends for Immuron.
Immuron’s H1 earnings are confirmed for Monday, April 1, 2024.
There is no upcoming split for Immuron.
Immuron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.